Alnylam Pharmaceuticals, Inc. (ALNY) financial statements (2021 and earlier)

Company profile

Business Address 675 WEST KENDALL STREET
CAMBRIDGE, MA 02142
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,8741,5361,0841,6916271,081697
Cash and cash equivalents49754742064519418175
Short-term investments1,3789896641,045433900622
Restricted cash and investments200    
Receivables10243193423840
Inventory, net of allowances, customer advances and progress billings755624    
Inventory755624    
Other undisclosed current assets560807340221710
Total current assets:2,6151,7161,2011,7656721,105746
Noncurrent Assets
Operating lease, right-of-use asset241221
Property, plant and equipment4654253211821152822
Long-term investments and receivables   14325252280
Long-term investments   14325252280
Restricted cash and investments41154530150  
Other noncurrent assets45189421 
Other undisclosed noncurrent assets      32
Total noncurrent assets:792679374230591281333
TOTAL ASSETS:3,4072,3951,5751,9951,2631,3871,080
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities408247172101974646
Accounts payable52506028541715
Accrued liabilities35619711372422924
Employee-related liabilities      7
Deferred revenue12778
Debt 28     
Deferred rent credit  4
Deferred revenue and credits44351725
Deferred tax liabilities    32
Contract with customer, liability3
Other undisclosed current liabilities50     (7)
Total current liabilities:5853531791441326295
Noncurrent Liabilities
Long-term debt and lease obligation4842763030150  
Long-term debt, excluding current maturities191 3030150  
Operating lease, liability293276
Liabilities, other than long-term debt2633286354616048
Deferred revenue and credits50585848
Deferred revenue225318
Contract with customer, liability0
Deferred rent credit  58
Other liabilities3895431 
Other undisclosed noncurrent liabilities1,058      
Total noncurrent liabilities:1,80660493842116048
Total liabilities:2,391956273228343122143
Stockholders' equity
Stockholders' equity attributable to parent1,0161,4391,3021,7669201,265936
Common stock1111111
Additional paid in capital5,6445,2014,1753,9482,6102,5061,843
Accumulated other comprehensive income (loss)(44)(37)(33)(34)(33)449
Accumulated deficit(4,585)(3,727)(2,841)(2,148)(1,657)(1,247)(957)
Total stockholders' equity:1,0161,4391,3021,7669201,265936
TOTAL LIABILITIES AND EQUITY:3,4072,3951,5751,9951,2631,3871,080

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues4932207590474151
Revenue, net90474151
Cost of revenue(78)(25)(22)    
Cost of goods and services sold(78)(25)(2)    
Gross profit:4151955390474151
Operating expenses(1,243)(1,134)(867)(590)(472)(337)(456)
Operating loss:(828)(939)(815)(500)(425)(296)(405)
Nonoperating income (expense)(27)545491464
Investment income, nonoperating12332912865
Other nonoperating income (expense)46114(3)602
Interest and debt expense(84)      
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes84(1)     
Loss from continuing operations before equity method investments, income taxes:(856)(886)(761)(491)(410)(290)(401)
Other undisclosed income from continuing operations before income taxes 1     
Loss from continuing operations before income taxes:(856)(885)(761)(491)(410)(290)(401)
Income tax expense (benefit)(3)(1)(1)   40
Net loss available to common stockholders, diluted:(858)(886)(761)(491)(410)(290)(360)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(858)(886)(761)(491)(410)(290)(360)
Other comprehensive income (loss)(7)(3)1(1)   
Comprehensive loss:(865)(889)(760)(492)(410)(290)(360)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (38)(44)29
Comprehensive loss, net of tax, attributable to parent:(865)(889)(760)(492)(448)(334)(331)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: